Crinetics Pharmaceuticals, Inc. (CRNX) Operating margin 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) operating margin by fiscal year — reported operating income divided by reported revenue.
-6714.8%FY2025 · since FY2016: -1026.1% → -6714.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6714.8% | +25898.7 pp |
| FY2024 | -32613.5% | -27066.3 pp |
| FY2023 | -5547.2% | — |
| FY2020 | -105567.6% | -101055.3 pp |
| FY2019 | -4512.3% | -3329.9 pp |
| FY2018 | -1182.5% | -736.1 pp |
| FY2017 | -446.3% | +579.8 pp |
| FY2016 | -1026.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice